Vaccine News and Research

Latest Vaccine News and Research

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

How well does the BNT162b2 vaccine protect children and teens against Omicron?

How well does the BNT162b2 vaccine protect children and teens against Omicron?

TLR7 and MARK1 genomic variants impact COVID-19 prognosis

TLR7 and MARK1 genomic variants impact COVID-19 prognosis

COVID-19 vaccine can cause temporary delay in menstruation

COVID-19 vaccine can cause temporary delay in menstruation

Global study demonstrates some benefits of flu vaccine in people with heart failure

Global study demonstrates some benefits of flu vaccine in people with heart failure

Clinical health outcomes of omicron ‘less severe’ than delta for pediatric patients

Clinical health outcomes of omicron ‘less severe’ than delta for pediatric patients

Health and Social Care Secretary announces an extension on the cancer call for evidence to April 8

Health and Social Care Secretary announces an extension on the cancer call for evidence to April 8

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Study reveals how zinc supports immunity, suggests ways it could be used to improve health

Study reveals how zinc supports immunity, suggests ways it could be used to improve health

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Potential new approach could make Japanese encephalitis vaccine more affordable

Potential new approach could make Japanese encephalitis vaccine more affordable

The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

UIC researchers projected to receive $22 million to study long COVID-19

UIC researchers projected to receive $22 million to study long COVID-19

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

KHN’s ‘What the Health?’: Funding for the next pandemic

KHN’s ‘What the Health?’: Funding for the next pandemic

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.